MYC and lymphoma: It will be of interest for future studies to consider evaluating inclusion/exclusion criteria, such as MYC rearrangement (including double-hit status), PBIP, EBV positivity, history of lymphoma, organ transplantation, and medical predisposition for fluid overload, to further support/refine or refute this new diagnostic entity.